OraSure Technologies Terminates Assay Collaboration Agreement with Roche Diagnostics

By: Benzinga
OraSure Technologies (NASDAQ: OSUR ) announced today that its assay collaboration agreement with Roche Diagnostics (OTC: RHHBY ) has been terminated. As part of the termination, Roche will continue to supply certain of the assays developed under that collaboration on a transitional basis for use with OraSure's existing
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.